Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2012 2
2013 1
2014 1
2015 1
2016 3
2017 1
2018 1
2020 2
2021 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Diagnostic value of immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysis.
Nagler M, Bachmann LM, ten Cate H, ten Cate-Hoek A. Nagler M, et al. Blood. 2016 Feb 4;127(5):546-57. doi: 10.1182/blood-2015-07-661215. Epub 2015 Oct 30. Blood. 2016. PMID: 26518436 Free article. Review.
Immunoassays are essential in the workup of patients with suspected heparin-induced thrombocytopenia. However, the diagnostic accuracy is uncertain with regard to different classes of assays, antibody specificities, thresholds, test variations, and man …
Immunoassays are essential in the workup of patients with suspected heparin-induced thrombocytopenia. However, the d …
Diagnostic accuracy of rapid immunoassays for heparin-induced thrombocytopenia. A systematic review and meta-analysis.
Sun L, Gimotty PA, Lakshmanan S, Cuker A. Sun L, et al. Thromb Haemost. 2016 May 2;115(5):1044-55. doi: 10.1160/TH15-06-0523. Epub 2016 Jan 14. Thromb Haemost. 2016. PMID: 26763074 Review.
The platelet factor 4/heparin ELISA has limited specificity for heparin-induced thrombocytopenia (HIT) and frequently does not provide same-day results. ...Twenty-three articles, collectively involving six different RIs, met eligibility criteria. All R …
The platelet factor 4/heparin ELISA has limited specificity for heparin-induced thrombocytopenia (HIT) and frequently d …
Diagnostic accuracy of IgG-specific versus polyspecific enzyme-linked immunoassays in heparin-induced thrombocytopenia: a systematic review and meta-analysis.
Husseinzadeh HD, Gimotty PA, Pishko AM, Buckley M, Warkentin TE, Cuker A. Husseinzadeh HD, et al. J Thromb Haemost. 2017 Jun;15(6):1203-1212. doi: 10.1111/jth.13692. Epub 2017 May 11. J Thromb Haemost. 2017. PMID: 28374939 Free PMC article. Review.
Essentials Immunoassay specificity varies in heparin-induced thrombocytopenia (HIT) testing. This meta-analysis examined 9 studies that tested samples by both IgG and polyspecific methods. ...SUMMARY: Background There are conflicting data on whether the IgG-s …
Essentials Immunoassay specificity varies in heparin-induced thrombocytopenia (HIT) testing. This meta-analysis examine …
Systematic review of fondaparinux for heparin-induced thrombocytopenia: When there are no randomized controlled trials.
Linkins LA, Hu G, Warkentin TE. Linkins LA, et al. Res Pract Thromb Haemost. 2018 Aug 9;2(4):678-683. doi: 10.1002/rth2.12145. eCollection 2018 Oct. Res Pract Thromb Haemost. 2018. PMID: 30349886 Free PMC article.
BACKGROUND: Fondaparinux is commonly used for treatment of heparin-induced thrombocytopenia (HIT) despite lack of approval for this indication. ...Selected studies enrolled consecutive adult patients who received fondaparinux as the primary anticoagulant to t …
BACKGROUND: Fondaparinux is commonly used for treatment of heparin-induced thrombocytopenia (HIT) despite lack of appro …
Thrombosis and Bleeding in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: A Systematic Review of Published Cases.
Clerici B, Pontisso E, Aloise C, Peroni B, Perricone R, Pisetta C, Scavone M, Birocchi S, Podda GM. Clerici B, et al. Thromb Haemost. 2024 May;124(5):423-431. doi: 10.1055/s-0043-1777134. Epub 2023 Dec 18. Thromb Haemost. 2024. PMID: 38109906
METHODS: We performed a systematic review of the literature (PubMed and Embase) up to July 31, 2022, including case reports and case series providing nonaggregate data of VITT patients. Accurate VITT diagnosis required fulfillment of the following criteria: (1) endo …
METHODS: We performed a systematic review of the literature (PubMed and Embase) up to July 31, 2022, including case reports and case series …
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Hamulyák EN, Scheres LJ, Marijnen MC, Goddijn M, Middeldorp S. Hamulyák EN, et al. Cochrane Database Syst Rev. 2020 May 2;5(5):CD012852. doi: 10.1002/14651858.CD012852.pub2. Cochrane Database Syst Rev. 2020. PMID: 32358837 Free PMC article.
MAIN RESULTS: Eleven studies (1672 women) met the inclusion criteria; nine randomised controlled trials and two quasi-RCTs. The studies were conducted in the USA, Canada, UK, China, New Zealand, Iraq and Egypt. ...No women in either the heparin plus aspirin group or the as …
MAIN RESULTS: Eleven studies (1672 women) met the inclusion criteria; nine randomised controlled trials and two quasi-RCTs. The studi …
Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis.
Cuker A, Gimotty PA, Crowther MA, Warkentin TE. Cuker A, et al. Blood. 2012 Nov 15;120(20):4160-7. doi: 10.1182/blood-2012-07-443051. Epub 2012 Sep 18. Blood. 2012. PMID: 22990018 Free PMC article. Review.
The 4Ts is a pretest clinical scoring system for heparin-induced thrombocytopenia (HIT). Although widely used in clinical practice, its predictive value for HIT in diverse settings and patient populations is unknown. ...We searched PubMed, Cochrane Database, …
The 4Ts is a pretest clinical scoring system for heparin-induced thrombocytopenia (HIT). Although widely used in clinic …
Heparin for the treatment of thrombosis in neonates.
Romantsik O, Bruschettini M, Zappettini S, Ramenghi LA, Calevo MG. Romantsik O, et al. Cochrane Database Syst Rev. 2016 Nov 7;11(11):CD012185. doi: 10.1002/14651858.CD012185.pub2. Cochrane Database Syst Rev. 2016. PMID: 27820879 Free PMC article. Review.
Whether preterm infants are at increased risk is unclear. No data are available on the frequency of osteoporosis, heparin-induced thrombocytopenia (HIT), or other hypersensitivity reactions in children and neonates exposed to LMWH. ...We searched clinical tri …
Whether preterm infants are at increased risk is unclear. No data are available on the frequency of osteoporosis, heparin-induced …
Platelets and extra-corporeal membrane oxygenation in adult patients: a systematic review and meta-analysis.
Jiritano F, Serraino GF, Ten Cate H, Fina D, Matteucci M, Mastroroberto P, Lorusso R. Jiritano F, et al. Intensive Care Med. 2020 Jun;46(6):1154-1169. doi: 10.1007/s00134-020-06031-4. Epub 2020 Apr 23. Intensive Care Med. 2020. PMID: 32328725 Free PMC article. Review.
Twenty-one studies from 1.742 abstracts were selected. The pooled prevalence of thrombocytopenia in ECMO patients was 21% (95% CI 12.9-29.0; 14 studies). ...Heparin-induced thrombocytopenia prevalence was 3.7% (95% CI 1.8-5.5; 12 studies). ...
Twenty-one studies from 1.742 abstracts were selected. The pooled prevalence of thrombocytopenia in ECMO patients was 21% (95% CI 12. …
COVID-19 Vaccine-Associated Thrombosis With Thrombocytopenia Syndrome (TTS): A Systematic Review and Post Hoc Analysis.
Hafeez MU, Ikram M, Shafiq Z, Sarfraz A, Sarfraz Z, Jaiswal V, Sarfraz M, Chérrez-Ojeda I. Hafeez MU, et al. Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211048815. doi: 10.1177/10760296211048815. Clin Appl Thromb Hemost. 2021. PMID: 34698582 Free PMC article.
BACKGROUND: A new clinical syndrome has been recognized following the COVID-19 vaccine, termed thrombosis with thrombocytopenia syndrome (TTS). The following systematic review focuses on extrapolating thrombotic risk factors, clinical manifestations, and outcomes of patien …
BACKGROUND: A new clinical syndrome has been recognized following the COVID-19 vaccine, termed thrombosis with thrombocytopenia syndr …
13 results